Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from LIFEDRINK COMPANY INC. ( (JP:2585) ) is now available.
LifeDrink Company Inc. has issued corrections to its previously announced consolidated financial results for the nine months ended December 31, 2025, adjusting key per-share figures and share data. The company slightly raised reported earnings per share and diluted earnings per share, and revised the number of treasury shares and average shares outstanding, changes that fine-tune its reported profitability metrics and may affect investor analysis of its capital structure.
The company also corrected its full-year forecast for the fiscal year ending March 31, 2026, leaving revenue and profit yen amounts unchanged but lowering the year-on-year growth rates for revenue, operating profit, ordinary profit, and profit attributable to owners of parent. While the absolute earnings outlook remains intact, the moderated growth percentages suggest a less aggressive expansion trajectory than initially indicated, which could temper market expectations regarding the company’s pace of performance improvement.
The most recent analyst rating on (JP:2585) stock is a Hold with a Yen1293.00 price target. To see the full list of analyst forecasts on LIFEDRINK COMPANY INC. stock, see the JP:2585 Stock Forecast page.
More about LIFEDRINK COMPANY INC.
LifeDrink Company Inc. is a Japan-based beverage manufacturer listed on the Prime Market of the Tokyo Stock Exchange. The company operates under Japanese GAAP reporting standards and targets consumers in its domestic market through the production and sale of drinks, positioning itself within the broader food and beverage industry.
Average Trading Volume: 626,835
Technical Sentiment Signal: Sell
Current Market Cap: Yen62.95B
For an in-depth examination of 2585 stock, go to TipRanks’ Overview page.

